Cargando…
Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?
Despite extensive research, pancreatic ductal adenocarcinoma (PDAC) remains a difficult-to-treat cancer associated with poor survival. Due to the known aggressive disease biology, palliative chemotherapy is the only routinely recommended treatment in the metastatic setting in patients with adequate...
Autores principales: | Ghidini, Michele, Petrillo, Angelica, Salati, Massimiliano, Khakoo, Shelize, Varricchio, Antonio, Tomasello, Gianluca, Grossi, Francesco, Petrelli, Fausto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721290/ https://www.ncbi.nlm.nih.gov/pubmed/31374916 http://dx.doi.org/10.3390/cancers11081095 |
Ejemplares similares
-
Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?
por: Khakoo, Shelize, et al.
Publicado: (2021) -
Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2023) -
Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies
por: Petrelli, Fausto, et al.
Publicado: (2019) -
Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysis
por: Tomasello, Gianluca, et al.
Publicado: (2022) -
Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2021)